Esperion Therapeutics ESPR 深 沪
等待开盘 08-05 09:30:00 美东时间
1.49
+0.090
+6.43%
华盛通- 最 高1.52
- 今 开1.43
- 成交量 445.82万股
- 最 低 1.38
- 昨 收 1.40
- 总市值 2.95亿
- 52周最高 3.94
- 市盈率 静 --
- 换手率 2.25%
- 52周最低 0.6925
- 委 比 77.38%
- 总股本 1.98亿
- 历史最高 120.96
- 量 比 1.04
- 振 幅 10.00%
- 历史最低 0.6925
- 每 手 1
- 风险率 0.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Esperion Therapeutics Q2 EPS $(0.02) Beats $(0.14) Estimate, Sales $82.385M Beat $63.142M Estimate
Esperion Therapeutics (NASDAQ:ESPR) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.14) by 85.51 percent. This is a 93.94 percent increase over losses of $(0.33) per share
50分钟前
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
今天 16:32
What to Expect from Esperion Therapeutics's Earnings
Esperion Therapeutics (NASDAQ:ESPR) is gearing up to announce its quarterly ear...
今天 05:02
CTI华测检测签署协议收购希腊Emicert公司控股权，加速布局欧盟可持续发展市...
近期，华测检测认证集团股份有限公司（简称CTI华测检测，股票代码：300012）与希腊Emicert公司完成控股权收购的协议签署，预计将于2025年第三季度完成...
07-30 09:21
Esperion Therapeutics soars amid vague takeover speculation
Esperion Therapeutics (NASDAQ:ESPR) jumped 20% amid some vague takeover speculation. Otsuka (OTCPK:OTSKY) is reportedly in talks to acquire full rights or possibly all of Esperion Therapeutics, accor...
07-25 01:47
Esperion to Report Second Quarter 2025 Financial Results on August 5
Esperion Therapeutics announced it will report second quarter 2025 financial results on August 5, 2025, and management will host a webcast at 8:00 a.m. ET to discuss the results. A live audio webcast is available on the company's investor section, with a replay accessible approximately two hours after the call and archived for 90 days. Esperion is a biopharmaceutical company focused on developing and commercializing innovative treatments for card...
07-22 12:00
徐斌：欧盟电池法规概况及汽车行业相关后续进展
专题：2025中国汽车论坛 2025年7月10-12日，2025中国汽车论坛在上海嘉定举办。本届论坛主题为“提质向新，智赢未来”，由“闭门...
07-18 11:48
亿联网络与TÜV南德签署战略协议，共筑通信设备全生命周期合规体系
中国/厦门 7月15日下午，厦门亿联网络技术股份有限公司（以下简称“亿联网络”）与TÜV南德意志集团（以下简称“TÜV南德”）正式签署战略合作协议。亿联网络全球...
07-17 16:32
Esperion settles litigation with Accord Healthcare
Esperion (NASDAQ:ESPR) said on Tuesday it has signed a settlement agreement with Accord Healthcare, delaying generic Nexletol until 2040. The litigation was in response to Accord Healthcare's applicat...
07-08 21:02
Esperion Announces It Has Reached Settlement Agreement With Third Abbreviated New Drug Application Filer Not To Market Generic Version Of NEXLETOL Prior to April 19, 2040
Esperion (NASDAQ:ESPR) today announced that it has entered into a settlement agreement with Accord Healthcare Inc. This agreement resolves the patent litigation brought by Esperion against Accord Healthcare Inc. in
07-08 20:08
